Effective Anticoagulation with Factor Xa Next Generation in Atrial Fibrillation – (Engage Af – Timi 48 Trial): Primary Results

Robert Giugliano

Associate Professor of Medicine, Harvard Medical School, Cambridge, Massachusetts, USA

Citation: EMJ Cardiol;1(Suppl 1):6-7

Presentation Summary

The following is an executive summary of the abstract presentation by Prof Robert Giugliano on the ENGAGE AF – TIMI 48 trial primary results. It was presented on 19th November 2013 at the American Heart Association (AHA) annual congress, held in Dallas, Texas.

Download (PDF, 63KB)

Leave a Reply